Please assess the completion status of the following clinical trial:

Trial Title: A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV coinfected with HCV and/or HBV.~* Undetectable HIV-1 RNA for at least 3 months prior to the screening visit~* Treatment with current antiretroviral therapy (3-6 drugs excluding low-dose ritonavir) for at least 5 months.~Exclusion Criteria:~* Currently receiving maraviroc.~* Active opportunistic infections.~* ALT and/or AST \>5x upper limit of normal.~* Direct bilirubin \>1.5x upper limit of normal.~* Severe or decompensated liver disease.~* Liver disease unrelated to viral hepatitis infection.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1.0 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).